TL;DR
HHS has launched a three-part Kidney Care National Plan aimed at preventing kidney failure, expanding treatment options at home and reforming organ donation and transplantation. The department says the initiative is intended to restore competition in dialysis, but its Tuesday statement does not detail the policies, funding or timeline that will put the goals into effect.
The U.S. Department of Health and Human Services has launched a Kidney Care National Plan to prevent kidney failure, expand treatment options at home and reform organ donation and transplantation, according to a Tuesday department statement. HHS says the initiative is also intended to restore competition in dialysis, a significant goal for patients and Medicare as kidney disease care carries substantial costs.
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
HHS describes the plan as a three-pronged initiative: detect, prevent and treat kidney disease before it progresses to kidney failure; improve dialysis care, including access to home treatment; and modernize the organ donation and transplantation system, including the Organ Procurement and Transplantation Network. The announcement sets out these aims but provides limited information on specific policies, funding or implementation dates.
The department links the effort to President Donald Trump’s 2019 executive order on kidney health, which directed the HHS secretary to select a payment model intended to encourage greater use of home dialysis among Medicare beneficiaries. HHS said home dialysis use rose from 10.5% in 2017 to 16% in 2023, reaching its highest level in a decade. Those figures describe the share of patients using home dialysis; they do not establish what portion of the change resulted from the executive order.
The financial stakes are considerable. Medicare spending for people with end-stage renal disease, which requires dialysis or a kidney transplant, reached $55.3 billion in 2023, according to the source report. The plan’s goals could affect how treatment is delivered and how the federal program pays for it, but the announcement does not specify expected savings or patient outcomes.
Home Dialysis and Medicare Costs
The plan puts home-based kidney treatment and dialysis-market competition on the federal agenda at a time when Medicare spending for end-stage renal disease is high. Home treatment may give some patients an alternative to traveling to an in-center facility, though suitability depends on individual circumstances and care arrangements. HHS has not provided a target for how many additional patients it expects to treat at home.
The competition goal matters because the department’s secretary argues that the existing kidney-care market has limited innovation. That is an administration position, not an independently established finding in the announcement. If HHS changes payment rules or other requirements, the effects could reach dialysis providers, clinicians, patients and organizations involved in home care. The plan’s real impact will depend on the specific measures adopted and whether they change access, quality or costs.
Products Worth Considering

Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor

BowFlex Results Series 552 SelectTech Adjustable Dumbbell

Levoit Vital 100S-P Air Purifier with Washable Pre-Filter
As an affiliate, we earn on qualifying purchases.
Earlier Federal Push for Home Care
The plan follows years of federal efforts to expand kidney treatment beyond clinics. The 2019 executive order called for a Medicare payment model encouraging home dialysis, and HHS points to the subsequent increase in home use as evidence that policy can influence treatment patterns. The figures alone, however, do not show the causes of that increase or how many patients could safely and practically receive treatment at home.
Home dialysis can include hemodialysis, in which a machine circulates blood through an external filter to remove waste and extra fluid and help regulate blood pressure and mineral levels, according to the National Institute of Diabetes and Digestive and Kidney Diseases. The source report also cited a rise in the share of people receiving dialysis at home, from 14.1% at the end of 2011 to a reported 45% increase by the end of 2021. That comparison is presented as a percentage increase, not a 45-percentage-point change.
Industry activity has also pointed toward more home-based kidney care. Earlier in 2026, Ares’ Private Equity Group and DaVita made a strategic investment in Elara Caring; the companies agreed to develop a kidney-specific home care model. That private-sector development is separate from the new federal plan.
“The lack of innovation in kidney care and the anticompetitive kidney market is the structural outcome of burdensome actions and regulations that have sustained a national crisis of kidney disease.”
— HHS Secretary Robert F. Kennedy Jr., in the department’s Tuesday statement
Policy Details Still Pending
HHS has not yet set out the plan’s implementation schedule, funding, or specific regulatory and payment changes. The announcement does not say whether new incentives will be created, which agencies or providers will carry them out, or how progress will be measured.
It is also unclear how the administration defines restoring competition, what changes it may seek in the dialysis market, or how transplantation reforms will be designed. The source material does not provide projected savings, targets for home dialysis adoption, or evidence that the plan will reduce kidney failure. Those outcomes remain goals rather than confirmed results.
Awaiting Implementation Measures
The next substantive step will be for HHS to publish or announce the specific actions behind the plan, including any payment-model decisions, regulatory proposals, implementation dates and measures for evaluating patient access and outcomes. Further detail will also be needed to determine how the department intends to modernize transplantation and address dialysis competition.
Until those measures are released, the announcement establishes the administration’s priorities but does not change treatment arrangements on its own. Patients, providers and Medicare stakeholders will need to assess the details as HHS clarifies how the plan is to be carried out.
Key Questions
What is the HHS Kidney Care National Plan?
It is a federal initiative focused on preventing kidney failure, improving dialysis care and reforming organ donation and transplantation, according to HHS.
Does the plan require patients to switch to home dialysis?
No such requirement was described in the announcement. HHS says the plan aims to expand treatment options at home; it has not announced a mandate or provided individual treatment guidance.
How much did Medicare spend on end-stage renal disease care?
The source report says total Medicare costs for people with end-stage renal disease reached $55.3 billion in 2023. That figure covers the stated year and condition; it is not a projection of savings from the new plan.
When will the plan take effect?
HHS announced the plan on Tuesday, October 20, 2026, but the announcement described here did not give an implementation timeline or specify when particular policies would begin.
Source: rss
